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Background: Menopause, a natural phenomenon, is defined by the fall of ovarian hormones mainly estrogens causing major problems 
such as insulin resistance. Fenugreek (Trigonella foenum-graecum) is known to have some useful properties such as insulin sensitizing 
effect. Apelin is an adipokine, which has several roles such as regulation of insulin secretion.
Objectives: The objective of the present study was to evaluate the effect of fenugreek seed and 17-β estradiol on serum Apelin along with 
glucose, lipids and insulin in ovariectomized rats.
Materials and Methods: Forty-nine adult female Wistar rats were randomly divided to seven groups: normal control, ovariectomized 
control, ovariectomized treated with ethanolic and hexanic extract of fenugreek seed (50 and 150 mg/kg/daily for each), and ovariectomized 
treated with 17-β estradiol (10 µg/kg/daily) for 42 days. Serum Apelin, glucose, lipids and insulin were measured.
Results: Serum Apelin, glucose, lipids and insulin significantly increased in ovariectomized controls in comparison with normal controls 
(P < 0.05). Serum glucose, lipids and insulin in ovariectomized rats treated with fenugreek seed extract and 17-β estradiol were remarkably 
lower than ovariectomized controls (P < 0.05). Furthermore, 17-β estradiol caused a significant decrease (P < 0.05) in serum Apelin in 
ovariectomized rats.
Conclusions: It appears that fenugreek seed might be effective against hyperglycemia, hyperlipidemia and insulin resistance in 
ovariectomized rats without impact on serum Apelin. Furthermore, 17-β estradiol could have similar effects along with possible inhibitory 
effects on serum Apelin. The complicated role of Apelin in menopause needs to be further explored.
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1. Background
Menopause is a natural event characterized by follicular 
atresia and fall in the secretion of ovarian hormones es-
pecially estrogens (1). This condition leads to physiologi-
cal and biochemical changes in affected females such as 
increased blood pressure, insulin resistance, and dyslip-
idemia (2). These changes are associated with increased 
risk of metabolic syndrome and some chronic diseases 
such as cardiovascular diseases (3).
Menopause usually occurs in middle-aged women; 
between 45 and 55 years (4). According to a survey, the 
number of perimenopausal or postmenopausal females 
would be about 1.2 billion by the year 2030 (5). Since 
menopause mostly affects females for about a third of 
their lives, providing a new effective approach for the pre-
vention of menopause complications or decreasing the 
risk of associated diseases could be helpful in enhancing 
health and quality of life among females.
Apelin is an adipokine with a number of active molecu-
lar forms, which is expressed in different tissues such as 
adipocytes (6). Apelin has several important roles such 
as regulation of insulin secretion through autocrine/
paracrine stimulation (7), and inhibition of lipolysis in 
adipocytes (8). The role of Apelin in lowering blood glu-
cose and insulin sensitivity has been suggested by previ-
ous studies (9). Assessment of the possible interaction 
between Apelin signaling, lipid metabolism, and beta 
cell function could be worthy of investigation (10). Fenu-
greek (Trigonella foenum-graecum), as an annual medici-
nal plant, is a member of the Fabaceae family. Fenugreek 
seed has been used to promote health and as a choice 
for the management of various human diseases such as 
diabetes, dyslipidemia and obesity (11, 12). The insulin 
sensitizing action of fenugreek has been proposed by 
earlier studies (13).
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2. Objectives
For the first time, the present study aimed to evaluate 
the effect of fenugreek seed and 17-β estradiol on the se-
rum level of Apelin along with glucose, lipids and insulin 
in ovariectomized (OVX) rats as a model of menopause.
3. Materials and Methods
3.1. Animals
Forty-nine adult female Wistar rats weighing 190 - 220 
g, obtained from the Institute of Pasteur, were used. 
Ethical clearance from this experimental study was ap-
proved by the ethical committee at Guilan university 
of medical sciences and the experiments were done in 
agreement with internationally accepted principles for 
laboratory animal use and cares as found in US guide-
lines (NIH publication #85-23, revised in 1985). Animals 
were housed in a room maintained at 21 to 23°C with a 
12 hours light/dark cycle. All rats had free access to food 
and water.
3.2. Study Design
After an adaptation period of two weeks, all rats were 
randomly divided to seven groups (seven rats in each 
group) as follows:
1) Normal control; receiving daily saline.
The remaining six groups were allocated to undergo bi-
lateral ovariectomy as follows (14):
2) OVX control; receiving daily saline.
3) OVX treated daily with 50 mg/kg of ethanolic extract 
of fenugreek seed (EEFS).
4) OVX treated daily with 150 mg/kg of EEFS.
5) OVX treated daily with 50 mg/kg of hexanic extract of 
fenugreek seed (HEFS).
6) OVX treated daily with 150 mg/kg of HEFS.
7) OVX treated daily with 10 µg/kg of estradiol.
Treatment began one day after ovariectomy by Intra-
peritoneal (IP) injection and all rats were maintained 
for 42 days on their respective treatments. The weight 
and fasting blood sugar (FBS) of all rats were measured 
at the beginning of the research and on the 42nd day 
of treatment. Blood glucose was measured by a glucom-
eter (Accu chek, Roche, Germany). After 42 days, fast-
ing whole blood samples were obtained from the vein 
of the tail. The serum of blood samples was separated 
immediately. The resulting sera were stored at -20°C. 
The serum levels of Apelin-13 and insulin were deter-
mined by using enzyme-linked immunosorbent assay 
(ELISA) kits (Shanghai Crystal Day Biotech Co., China). 
The serum levels of cholesterol, triglyceride (TG), low-
density Lipoprotein (LDL) and high-density lipoprotein 
(HDL) were determined by using commercial kits (Pars 
Azmoon, Iran).
3.3. Plant Material and Extraction
The seed of fenugreek was supplied by a grocery store 
in Rasht (Guilan province) during years 2013 and 2014, 
and the species was confirmed by the herbarium de-
partment of the agricultural research center at Guilan 
university. The voucher specimen 11411 was deposited in 
the Herbarium of the department of botany, faculty of 
agriculture, Guilan university. Preparation of the etha-
nolic and hexanic extracts was performed as previously 
described (11).
3.4. Chemicals
The 17-β estradiol was obtained from Sigma-Aldrich 
(GmbH, Germany). Ethanol and hexane were purchased 
from Merck (Germany).
3.5. Statistical Analysis
Data are presented as means ± standard error of the 
Mean (SEM) and inter-group comparisons were made us-
ing the one-way analysis of variance (ANOVA) followed by 
post hoc Tukey’s test. P values of < 0.05 were considered 
statistically significant. Analysis was performed using 
the SPSS software version 16.
4. Results
The average body weight of OVX control remarkably in-
creased in comparison to normal control rats (P < 0.05). 
Treatment of the OVX rats with HEFS, EEFS and estradiol 
resulted in a decrease in body weight (Table 1).
The serum level of cholesterol, TG and LDL remarkably 
increased while serum HDL significantly decreased in 
OVX control when compared to normal control rats (P 
< 0.05). However, HEFS, EEFS, and estradiol caused a re-
markable decrease in serum level of cholesterol and TG 
in OVX rats (P < 0.05). Following 42 days of treatment 
with HEFS at a dose of 150 mg/kg/day, EEFS at a dose of 
50 mg/kg/day and estradiol, the serum LDL was reduced. 
Only 17-β estradiol caused remarkable increase in the se-
rum level of HDL (Table 1).
The serum glucose and insulin significantly increased 
in OVX controls in comparison with normal control rats 
(P < 0.05) (Table 2).
The HEFS, EEFS, and estradiol rats showed a remarkable 
decrease in the serum levels of glucose and insulin when 
compared to OVX control rats (P < 0.05)(Table 2).
The serum level of Apelin was significantly higher in 
OVX control rats compared with normal control rats (P 
< 0.05). There were no significant differences in the level 
of serum Apelin between OVX rats treated with HEFS and 
EEFS as compared with OVX control rats. The 17-β estradiol 
caused a significant decrease (P < 0.05) in serum Apelin 
in ovariectomized rats (P < 0.05)(Table 2). 
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Table 1.  Effect of Fenugreek Seed and 17-β Estradiol on Body Weight, Serum Cholesterol, Low-Density Lipoprotein, High Density Lipo-
protein, and Triglyceride After Six Weeks in Normal Control and Ovariectomized Rats a,b
Groups Body weight, g Cholesterol, mg/dl LDL, mg/dl HDL, mg/dl Triglyceride, mg/dl
Normal control 233 ± 2 c 85 ± 2.6 51.7 ± 4.3 24 ± 1.92 60.1 ± 2.4
OVX control 247 ± 3 d 122 ± 9 c 83 ± 5.1 d 12 ± 2.64 d 115 ± 1.1 d
OVX + HEFS (50 mg/kg) 235 ± 3 c 80 ± 3 c 75.1 ± 4 d 18 ± 1 84.1 ± 3.9 c,d
OVX + HEFS (150 mg/kg) 233 ± 2 c 86 ± 4 c 60.2 ± 1.6 c 20 ± 2.31 71.5 ± 2.9 c
OVX + EEFS (50 mg/kg) 229 ± 3 c 93 ± 4 c 74.4 ± 3.1 c 14 ± 1.31 88.2 ± 4.2 c,d
OVX + EEFS (150 mg/kg) 231 ± 2 c 73 ± 5 c 69.8 ± 3.5 d 16 ± 2.41 79 ± 3.9 c,d
OVX + estradiol (10 µg/kg) 231 ± 1 c 100 ± 3 c,d 54.2 ± 5.1 c 29 ± 1.81 c 73.5 ± 4.2 c
a  Values are given as mean ± SEM.
b  Abbreviations: EEFS: ethanolic extract of fenugreek seed, HDL: high-density lipoprotein, HEFS: hexanic extract of fenugreek seed, LDL: low-density 
lipoprotein, OVX: ovariectomized.
c  P < 0.05 by comparison with ovariectomized control rats.
d  P < 0.05 by comparison with normal control rats.
Table 2.  Effect of Fenugreek Seed and 17-β Estradiol on Serum Glucose, Insulin and Apelin After Six Weeks in Normal Control and 
Ovariectomized Rats a,b
Groups Glucose, mg/dl Insulin, U/dl Apelin, µg/dl
Normal control 97 ± 2.04 489 ± 1.92 75.1 ± 1.5
OVX control 158 ± 1.95 c 700 ± 1.64 c 88.8 ± 1.9 c
OVX + HEFS (50 mg/kg) 132 ± 2.18 c,d 627 ± 1.21 c,d 86.2 ± 3.5
OVX + HEFS (150 mg/kg) 128 ± 3.18 c,d 600 ± 1.81 c,d 80 ± 1.9
OVX + EEFS (50 mg/kg) 135 ± 3.38 c,d 649 ± 1.01 c,d 80.7 ± 2.4
OVX + EEFS (150 mg/kg) 129 ± 2.61 c,d 616 ± 0.81 c,d 81.4 ± 4
OVX + estradiol (10 µg/kg) 134 ± 6.18 d 546 ± 2.81 c,d 72.1 ± 0.9 d
a  Values are given as mean ± SEM.
b  Abbreviations: EEFS: ethanolic extract of fenugreek seed, HEFS: hexanic extract of fenugreek seed, OVX: ovariectomized.
c  P < 0.05 by comparison with normal control rats.
d  P < 0.05 by comparison with ovariectomized control rats.
5. Discussion
The present study was undertaken to find out the ef-
fect of fenugreek seed extract and 17-β estradiol on se-
rum Apelin together with some of menopause related 
parameters such as serum lipids, glucose, and insulin 
level. Mean level of serum cholesterol, TG, and LDL in OVX 
control were significantly higher than those of normal 
control rats, whereas there was a statistically significant 
decrease of HDL in OVX control in comparison to normal 
control rats. These findings were similar to that found by 
the study of Goss et al. (15) in which ovariectomy caused a 
considerable increase in serum levels of cholesterol and 
LDL in comparison to normal rats. In another study (16), 
OVX rats showed no significant changes in TG, choles-
terol and HDL levels compared with normal rats. Meno-
pausal statement due to reduced estrogen secretion is 
associated with hyperlipidemia, which is defined by in-
creased level of cholesterol, TG, LDL, and decreased level 
of HDL (17). It has been demonstrated that estrogen has 
a physiological role in lowering cholesterol through up-
regulation of hepatic LDL receptor, consequently leading 
to an enhanced clearance of blood cholesterol (18).
The administration of HEFS and EEFS to OVX rats de-
creased serum cholesterol and TG compared with ovari-
ectomized control rats. These findings were consistent 
with those of Sharma et al. (19), where fenugreek seed led 
to a significant decrease of serum cholesterol and TG. Hy-
polipidemic effect of fenugreek seed was partly related 
to the decrease in fat accumulation, up-regulation of LDL 
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receptor and decrease in insulin, which could decrease 
the activity of pyruvate dehydrogenase and acetyl-CoA 
carboxylase involved in lipogenesis as well as activity of 
3-hydroxy-3-methylglutaryl-CoA reductase involved in 
cholesterol synthesis (20, 21). The role of fenugreek seed 
in the management of dyslipidemia and decreased risk 
of cardiovascular disease during the post menopause 
period was proposed (22). As compared with normal con-
trol rats, ovariectomy caused a considerable increase in 
the serum level of glucose and insulin. In the study of 
Mattace Raso et al. (23), no significant differences in se-
rum glucose and insulin between OVX and normal rats 
were found. Shinmura et al. reported no statistical differ-
ence in serum glucose between OVX and normal rats (24). 
In contrast to the present study, the study of Ahmadi et 
al. (25) showed significantly decreased serum insulin in 
OVX rats as compared with control animals. In line with 
the present study, Posa et al. demonstrated that serum 
insulin significantly increased in OVX rats (26), which 
could be regarded as a marker for developing an insulin-
resistant state. In addition, an increase in serum insulin 
may be due to the hyperactivity of the pancreatic islet 
cells to serum glucose (27). Serum glucose and insulin 
were considerably lower in OVX rats treated with HEFS 
and EEFS compared with OVX control animals. Zahedi et 
al. (28) revealed that plasma glucose in diabetic rats treat-
ed with fenugreek seed decreased compared to levels 
before treatment. It has been suggested that fenugreek 
seed causes a hypoglycemic effect through several mech-
anisms such as elevated glucose-stimulated insulin secre-
tion by pancreatic beta cells (29) and activation of insulin 
receptor by tyrosine phosphorylation (30). It is likely that 
supplementary therapy of fenugreek seed extract could 
be beneficial for the improvement of glycemic control 
and insulin resistance after menopause.
In the present study, there was a significant decrease in 
the serum level of glucose and insulin in OVX rats exposed 
to estradiol when compared to OVX control rats. How-
ever, Ahmadi and Oryan showed that estradiol was as an 
enhancer of serum insulin (25). You et al. identified that 
estradiol in OVX rats remarkably reduced serum glucose 
and insulin after six weeks (31). In addition, Li et al. showed 
that estrogen therapy might decrease blood insulin and 
glucose in menopausal females (32). It appears that estro-
gen by modulating insulin sensitivity or reducing insulin 
resistance (33) and lowering lipids (34) could be protective 
against metabolic abnormalities such as coronary artery 
disease (CAD) in menopausal females (31).
Ovariectomy led to a remarkable increase in serum 
Apelin in comparison to normal conditions. Boucher et 
al. showed that serum level of Apelin was considerably 
higher in moderately obese humans compared with the 
control group (6). Increased glucose in OVX rats may 
cause hyperactivity of pancreatic beta cells and increased 
insulin (27) and consequently increased Apelin (6). On 
the other hand, it has been suggested that Apelin has a 
role in decreasing the amount of glucose via enhanced 
glucose utilization in muscles (35), and in inhibition of 
insulin secretion through induction of phosphatidylino-
sitol 3-kinase and phosphodiesterase 3B (36). Therefore, 
increased serum Apelin in OVX animals appears to act 
partially as a regulatory mechanism; nevertheless, other 
possible theories need to be evaluated.
Serum level of Apelin was similar in OVX rats exposed 
to HEFS or EEFS and OVX control rats. Regarding the po-
tential effects of fenugreek seed on lipids, glucose, and 
insulin (22, 37, 38), it appears that these effects may not be 
mediated by serum Apelin. However, more relevant inves-
tigations are required to verify this theory.
In OVX animals, serum Apelin remarkably decreased 
during estradiol treatment compared with the control 
group. Considering the fact that estradiol has a lowering 
effect on serum insulin (31, 32) and insulin can elevate 
Apelin production (6), it appears that reduced serum 
Apelin under estradiol treatment in OVX rats can be, to 
some extent, due to decreased insulin. Because of the mi-
togenic role of Apelin in the epithelial (39) and endotheli-
al cells (40), this effect might be considered in agreement 
with the beneficial effects of hormone therapy in meno-
pausal females (32). Nevertheless, the complicated role of 
Apelin during menopause needs to be further explored.
Overall, it appears that fenugreek seed might be effec-
tive against hyperglycemia, hyperlipidemia and insulin 
resistance in OVX rats without impact on serum Apelin. 
The 17-β estradiol could have similar effects along with 
possible inhibitory effects on serum Apelin. Since Apelin 
may affect metabolism via several different mechanisms, 
more related investigations are needed to determine the 
potential effect of Apelin on menopausal conditions.
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